PMID- 32670276 OWN - NLM STAT- MEDLINE DCOM- 20210405 LR - 20210405 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 11 DP - 2020 TI - The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice. PG - 1157 LID - 10.3389/fimmu.2020.01157 [doi] LID - 1157 AB - Background: The receptor for advanced glycation end products (RAGE) is a multiligand receptor involved in a number of processes and disorders. While it is known that RAGE-signaling can contribute to toxic liver damage and fibrosis, its role in acute inflammatory liver injury and septic multiorgan failure is yet undefined. We examined RAGE in lipopolysaccharide (LPS) induced acute liver injury of D-galN sensitized mice as a classical model for tumor necrosis factor alpha (TNF-alpha) dependent inflammatory organ damage. Methods: Mice (Rage-/- and C57BL/6) were intraperitoneally injected with D-galN (300 mg/kg) and LPS (10 mug/kg). Animals were monitored clinically, and cytokines, damage associated molecular pattern molecules (DAMPs) as well as liver enzymes were determined in serum. Liver histology, hepatic cytokines as well as RAGE mRNA expression were analyzed. Cellular activation and functionality were evaluated by flow cytometry both in bone marrow- and liver-derived cells. Results: Genetic deficiency of RAGE significantly reduced the mortality of mice exposed to LPS/D-galN. Hepatocyte damage markers were reduced in Rage-/- mice, and liver histopathology was less severe. Rage-/- mice produced less pro-inflammatory cytokines and DAMPs in serum and liver. While immune cell functions appeared normal, TNF-alpha production by hepatocytes was reduced in Rage-/- mice. Conclusions: We found that RAGE deletion attenuated the expression of pro-inflammatory cytokines and DAMPs in hepatocytes without affecting cellular immune functions in the LPS/D-galN model of murine liver injury. Our data highlight the importance of tissue-specific RAGE-signaling also in acute inflammatory liver stress contributing to sepsis and multiorgan failure. CI - Copyright (c) 2020 Weinhage, Wirth, Schutz, Becker, Lueken, Skryabin, Wittkowski and Foell. FAU - Weinhage, Toni AU - Weinhage T AD - Department of Pediatric Rheumatology and Immunology, University of Munster, Munster, Germany. FAU - Wirth, Timo AU - Wirth T AD - Department of Neurology With Institute of Translational Neurology, University Hospital Munster, Munster, Germany. FAU - Schutz, Paula AU - Schutz P AD - Department of Pediatric Rheumatology and Immunology, University of Munster, Munster, Germany. FAU - Becker, Philipp AU - Becker P AD - Department of Pediatric Rheumatology and Immunology, University of Munster, Munster, Germany. FAU - Lueken, Aloys AU - Lueken A AD - Department of Pediatric Rheumatology and Immunology, University of Munster, Munster, Germany. FAU - Skryabin, Boris V AU - Skryabin BV AD - Core Facility of Transgenic Animal and Genetic Engineering Models (TRAM), University of Munster, Munster, Germany. FAU - Wittkowski, Helmut AU - Wittkowski H AD - Department of Pediatric Rheumatology and Immunology, University of Munster, Munster, Germany. FAU - Foell, Dirk AU - Foell D AD - Department of Pediatric Rheumatology and Immunology, University of Munster, Munster, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200603 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 0 (Ager protein, mouse) RN - 0 (Lipopolysaccharides) RN - 0 (Receptor for Advanced Glycation End Products) SB - IM MH - Animals MH - Inflammation/chemically induced/metabolism MH - Lipopolysaccharides/*toxicity MH - Liver Failure, Acute/*metabolism/pathology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Receptor for Advanced Glycation End Products/*metabolism MH - Sepsis/complications/metabolism/pathology PMC - PMC7326105 OTO - NOTNLM OT - DAMPs OT - PAMPs OT - RAGE OT - inflammatory liver injury OT - sepsis EDAT- 2020/07/17 06:00 MHDA- 2021/04/07 06:00 PMCR- 2020/01/01 CRDT- 2020/07/17 06:00 PHST- 2020/02/12 00:00 [received] PHST- 2020/05/11 00:00 [accepted] PHST- 2020/07/17 06:00 [entrez] PHST- 2020/07/17 06:00 [pubmed] PHST- 2021/04/07 06:00 [medline] PHST- 2020/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2020.01157 [doi] PST - epublish SO - Front Immunol. 2020 Jun 3;11:1157. doi: 10.3389/fimmu.2020.01157. eCollection 2020.